January 27, 2022 -- CuriRx has launched its Advanced Bioprocessing and Analytical Center to provide end-to-end support to the developers of biotherapeutics.
The center offers developers the ability to accelerate biotherapeutic drug development and overcome challenges by leveraging CuriRx's bioprocessing experience, its CuriLytics platform, and the latest methods in upstream and downstream process development, according to CuriRx.
CuriRx is a contract development and manufacturing organization that offers upstream and downstream process development, optimization, characterization, scale-up and scale down, analytical development, formulation development, and lyophilization services.